愉
08622
愉悅集團
0.229
+0.009+4.09%Closed15:51 06/05 HKT
OPEN/PREV CLOSE0.215/0.220
TODAY RANGE0.214-0.240
VOL64.00K
MARKET CAP121.65M
52 WEEK RANGE0.203-0.750
AVG VOL (3M)384.14K
% TURNOVER0.01%
TURNOVER14.04K
P/E (TTM)-21.852
% RANGE11.82%
EPS(TTM)-0.011
P/E(FORWARD)6.300
P/B2.149
BVPS0.110
DIVIDEND--
P/S3.888
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP121.65M
SHARES OUTSTANDING515.47M
NEXT EARNINGS--
FREE FLOAT515.47M
LOT SIZE8000
EX-DATE--
News
Press Releases
Financial Reports
Profile
PUBT·04/27 12:30
Joyzyme Group publishes 2025 annual report
Simply Wall St·04/02 23:01
Joyzyme Group Insiders Enjoying CN¥57m Appreciation On CN¥32.7m Investment
Reuters·03/30 10:43
Joyzyme Group files directors list with Hong Kong Stock Exchange
Reuters·03/30 10:41
Joyzyme Group says non-executive director Xu Ming resigns
Reuters·02/04 09:10
Huakang Biomedical Renames as Joyzyme Group
Reuters·01/15 08:47
Huakang Biomedical Holdings Co. Ltd. Held Extraordinary General Meeting
Reuters·12/22/2025 08:54
Huakang Biomedical Holdings Co. Ltd. Announces Date for Extraordinary General Meeting
Reuters·12/22/2025 08:51
Huakang Biomedical Proposes Company Name Change for Shareholder Vote at Upcoming EGM
Reuters·12/15/2025 09:52
Huakang Biomedical Moves Head Office to Kowloon
Reuters·12/11/2025 14:01
Huakang Biomedical Files Director List to HKEX
Reuters·12/11/2025 10:47
Anselme Limited Completes Cash Offer for Huakang Biomedical Holdings
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.